Edition:
United Kingdom

ConvaTec Group PLC (CTEC.L)

CTEC.L on London Stock Exchange

150.15GBp
4:50pm BST
Change (% chg)

-7.65 (-4.85%)
Prev Close
157.80
Open
153.50
Day's High
158.70
Day's Low
147.05
Volume
8,694,951
Avg. Vol
4,435,510
52-wk High
241.62
52-wk Low
140.00

Summary

Name Age Since Current Position

Christopher Gent

69 2016 Non-Executive Chairman of the Board

Rick Anderson

57 2018 Interim Chief Executive Officer, Director

Steve Holliday

61 2016 Deputy Chairman of the Board, Senior Non-Executive Independent Director

Frank Schulkes

56 2017 Chief Financial Officer, Executive Director

Peter Byloos

2018 Franchise President – Advanced Wound Care

Frank Gehres

2018 Franchise President – Continence and Critical Care

Kjersti Grimsrud

2018 President - EMEA

John Lindskog

58 Franchise President – Infusion Devices

Timothy Moran

46 President - Americas

George Poole

45 2015 President - APAC Region

Adam Deutsch

46 2017 Executive Vice President, General Counsel and Corporate Development

Sean McGrath

2018 Executive Vice President - Global Human Resources

Donal Balfe

2017 Executive Vice President - Global Operations

Robert Steele

60 2014 Executive Vice President - Quality, Regulatory & Clinical Affairs

Erik Zimmer

2018 Vice President and General Manager – Ostomy Care

Clare Bates

Company Secretary

Sten Scheibye

67 2018 Non-Executive Director

Regina Benjamin

61 2017 Non-Executive Independent Director

Margaret Ewing

63 2017 Non-Executive Independent Director

Jesper Ovesen

61 2016 Non-Executive Independent Director

Rosalind Rivaz

62 2017 Non-Executive Independent Director

Biographies

Name Description

Christopher Gent

Sir. Christopher Charles Gent is a Non-Executive Chairman of the Board of the Company. Sir Christopher has significant board level experience across global operations and a range of sectors, including healthcare. His previous board positions include Chief Executive of Vodafone, Chairman of GlaxoSmithKline, Chairman of the Supervisory Board of Mannesmann AG, board member of Verizon Wireless, board member of Ferrari, non-executive director of China Mobile (Hong Kong) Limited and non-executive director of Lehman Brothers. He was also a Senior Adviser to Bain & Company. He is currently a member of the international advisory board of Hakluyt.

Rick Anderson

Mr. Rick D. Anderson is Interim Chief Executive Officer, Director of the Company. He was previously Group Chairman of Johnson & Johnson and Worldwide Franchise Chairman of Cordis Corporation. Before joining Johnson & Johnson, Rick was Vice President of Global Marketing of Racal HealthCare and, prior to that, he was with Boehringer Mannheim Pharmaceuticals and Allergan Pharmaceuticals. Currently he is a Managing Director at PTV Healthcare Capital (“PTV”) and serves on the board of PTV’s portfolio company Apollo Endosurgery. He is also the Chair of the board for Cardiva Medical.

Steve Holliday

Mr. Steve J. Holliday is Deputy Chairman of the Board, Senior Non-Executive Independent Director of the Company. Steve was previously Chief Executive of National Grid plc, a role he held for over nine years until his retirement in July 2016, a board member of British Borneo Oil and Gas and the lead non-executive director at Defra. He also held senior management roles with Exxon in refining, shipping and international gas. Currently he is Vice-Chairman of Business in the Community and Vice-Chairman of the Careers and Enterprise Company, Chairman of the Board of Trustees at Crisis, the homeless charity and Chairman of Senvion S.A.. Steve is a fellow of the Royal Academy of Engineering.

Frank Schulkes

Mr. Frank Schulkes is Chief Financial Officer, Executive Director of the Company. Frank was previously CFO of Wittur Group, a privately-held industrial company based in Germany, prior to which he spent 27 years with GE in a variety of increasingly senior financial and planning roles. In 2007 he was appointed Executive Vice President and CFO of GE Healthcare, a position he held until mid-2015 when he left to join Wittur. GE Healthcare is a global medical technology, life sciences and services organisation with four divisions, revenues of $18 billion and 53,000 employees.

Peter Byloos

Frank Gehres

Kjersti Grimsrud

John Lindskog

Mr. John Lindskog is Franchise President – Infusion Devices of the Company. He is the President of Infusion Devices. Mr. Lindskog joined ConvaTec in 2008 when, as General Manager of Unomedical’s Infusion Device business unit, he helped lead the integration of Unomedical into ConvaTec. His 25 years of experience in the infusion devices industry began at Pharma- Plast, which later merged with Maersk Medical and became Unomedical. Mr. Lindskog holds a Bachelor’s degree in Business Administration through the internal academy at the East Asiatic Company in Denmark, and a Graduate certificate in Business Administration from Copenhagen Business School. He has completed the General Management Program at CEDEP-INSEAD business School in Fontainebleau in France.

Timothy Moran

Mr. Timothy Moran is President - Americas of the Company. He joined ConvaTec in 2015 from Medtronic, where he was Vice President and General Manager of the Patient Care and Safety Division. After joining Kendall in 1997, Mr. Moran was promoted to roles of increasing responsibility in sales, marketing and general management within Tyco Healthcare, Covidien and Medtronic. Prior to joining Kendall, he held sales positions with a number of medical and communications technology firms in the United States. Mr. Moran holds a Bachelor of Arts degree in Organisational Communication from the State University of New York at Geneseo.

George Poole

Mr. George Poole is President - APAC Region of the Company. He joined ConvaTec in 2015 from Medtronic, where he spent 14 years in leadership roles in commercial, marketing, operations and general management. For the last five years at Medtronic, Mr. Poole was a key member of Medtronic’s Asia Pacific management team, most recently serving as Vice President/Managing Director, Southeast Asia. Prior to Medtronic, he served in sales positions with Welch Allyn and Olympus America. Mr. Poole holds a Bachelor of Science degree in Economics from the State University of New York at Cortland.

Adam Deutsch

Mr. Adam Brent Deutsch is Executive Vice President, General Counsel and Corporate Development of the Company. Mr. Deutsch joined ConvaTec in 2014 from Biomet, Inc., a leading global medical device company. His roles included Corporate Vice President and Associate General Counsel—Litigation, Investigations & Risk Management, as well as Chief Compliance Officer. Prior to joining Biomet, Mr. Deutsch was a partner and associate with prominent law firms based in Chicago. He holds a Bachelor of Arts degree from Rutgers University and a Juris Doctor degree from New York University School of Law.

Sean McGrath

Donal Balfe

Robert Steele

Mr. Robert Steele is a Executive Vice President - Quality, Regulatory & Clinical Affairs of the Company. He joined ConvaTec in 2014 from Stryker. His most recent role was Vice President of Regulatory Affairs, Quality Assurance and Clinical. Prior to Stryker, Mr. Steele held a variety of roles with medical technologies company KCI, including Vice President of Global Quality. Mr. Steele began his career as an engineer working at medical device manufacturing companies in the United Kingdom. Mr. Steele holds a Bachelor of Arts degree in Electro Mechanical Engineering from Open University as well as two National Certificates in Mechanical Engineering and one in Electronic Engineering. He is a Chartered Engineer and Chartered Quality professional.

Erik Zimmer

Clare Bates

Sten Scheibye

Mr. Sten Scheibye is Non-Executive Director of the Company. Sten Scheibye was Chairman of the Novo Nordisk Foundation and of Novo Holdings A/S from 2013 and has recently retired from both these positions. He currently holds the position of Senior Advisor to Novo Holdings. He was appointed Chairman of Healthcare Denmark in 2015. He was a member of the Danish Corporate Governance Committee from 2003 - 2011, serving the last two years as Chairman, and from 1995 - 2008 he was the President and CEO of Coloplast A/S.

Regina Benjamin

Dr. Regina M. Benjamin, M.D., is Non-Executive Independent Director of the Company. Dr Benjamin was United States Surgeon General from 2009 - 2013 and is currently a Non-Executive Director of Diplomat Pharmacy, Inc, Kaiser Foundation Hospitals and Health Plan, and Ascension Hospital System. She is a former Non-Executive Director of Alere, Inc. From 1992-2004 she served on the board of the Medical Association of Alabama, and in 1995, Dr Benjamin became the first Young Physician to be elected to the American Medical Association Board of Trustees. In 2008, she was Chair of the Federation of State Medical Licensing Boards. Dr Benjamin is CEO and practising physician at the Bayou La Batre Rural Health Clinic in Alabama, which she founded in 1990 and holds an endowed chair in Public Health Sciences at Xavier University of Louisiana.

Margaret Ewing

Mrs. Margaret Ewing is Non-Executive Independent Director of the Company. Mrs. Ewing is currently a Trustee of the Board and Chairman of the Finance and Audit Committee of Great Ormond Street Hospital Children's Charity. She is also the Independent External member of the Audit Committee of the Lawn Tennis Association. Mrs Ewing was previously a Non-Executive Director of Standard Chartered plc, Whitbread plc and the Confederation of British Industry and the Independent External member of the Audit Committee of John Lewis Partnership plc. She was a corporate finance partner of Deloitte LLP between 1987 - 1999, returning to Deloitte in 2007 as a senior partner and retiring from the firm in 2012. During the period 2007 - 2012 Mrs Ewing was Vice Chairman and a member of the firm's Executive Committee and the Board, Senior Partner of the London practice and latterly Managing Partner for Public Policy, Quality and Risk. Mrs Ewing was Group Chief Financial Officer of Trinity Mirror plc from 2000 - 2002 and of BAA plc from 2002 - 2006. She was also a Member of the Financial Reporting Review Panel between 2011 - 2014.

Jesper Ovesen

Mr. Jesper Ovesen is Non-Executive Independent Director of the Company. Jesper’s previous board positions include Executive Chairman of Nokia Siemens Networks, Chief Financial Officer of TDC, Chief Executive of Kirkbi Group, Chief Financial Officer of The Lego Group and Danske Bank and the Audit Chair of FLSmidth & Co., Orkla Group and Danisco. He was also a director of corporate finance for Novo Nordisk A/S. He is currently Deputy Chairman of SEB, one of the largest banks in the Nordic region, and the Audit Chair of Lundbeck and Sunrise Communications Group. Jesper is a chartered accountant.

Rosalind Rivaz

Dr. Ros Rivaz serves as Non-Executive Independent Director of the Company. She was Chief Operating Officer of Smith & Nephew plc until 2014 and previously held senior management positions in global companies, including ICI, Tate & Lyle and Diageo, in the areas of supply chain management, logistics, manufacturing, IT, procurement and systems. She is a non-executive director of RPC Group plc, Computacenter plc, Boparan Holdings Limited and the MoD Defence Equipment and Support Board. She was previously a nonexecutive director of Rexam plc and Chair of its Remuneration Committee. She was also Vice-Chair of the Council of the University of Southampton, where she holds an honorary doctorate, until stepping down in July 2017, and a non-executive director of the Government sponsored Your Life initiative, which ran for three years until the end of 2017, and encouraged 14 to 16 year olds to pursue qualifications in mathematics and physics.